Zobrazeno 1 - 10
of 289
pro vyhledávání: '"Antonio, Bertolotto"'
Autor:
Clara G. Chisari, Umberto Aguglia, Maria Pia Amato, Roberto Bergamaschi, Antonio Bertolotto, Simona Bonavita, Vincenzo Brescia Morra, Paola Cavalla, Eleonora Cocco, Antonella Conte, Salvatore Cottone, Giovanna De Luca, Alessia Di Sapio, Massimo Filippi, Antonio Gallo, Claudio Gasperini, Franco Granella, Giacomo Lus, Davide Maimone, Giorgia Teresa Maniscalco, Girolama Marfia, Lucia Moiola, Damiano Paolicelli, Ilaria Pesci, Paolo Ragonese, Marco Rovaris, Giuseppe Salemi, Claudio Solaro, Rocco Totaro, Maria Trojano, Marika Vianello, Mauro Zaffaroni, Vito Lepore, Francesco Patti, Carlo Avolio, Roberto Balgera, Paola Banfi, Paolo Bellantonio, Placido Bramanti, Lorenzo Capone, Guido Cavalletti, Luca Chiveri, Raffaella Clerici, Marinella Clerico, Francesco Corea, Vincenzo Dattola, Francesca De Robertis, Giancarlo Di Battista, Simonetta Galgani, Maurizia Gatto, Maria Grazia Grasso, Matilde Inglese, Lorenzo Lo Russo, Francesco Ottavio Logullo, Renato Mantegazza, Alessandra Protti, Monica Rezzonico, Mariarosa Rottoli, Marco Salvetti, Elio Scarpini, Leonardo Sinisi, Maddalena Sparaco, Daniele Spitaleri, Tiziana Tassinari, Simone Tonietti, Paola Valentino, Franco Valzania, Simonetta Venturi
Publikováno v:
Neurotherapeutics, Vol 21, Iss 4, Pp e00363- (2024)
Treatment options for secondary progressive MS (SPMS) are limited, especially considering that the new drugs recently approved are licensed for actively relapsing patients. We aimed to compare the disability progression in a real-world cohort of SPMS
Externí odkaz:
https://doaj.org/article/26800f29a8714b44b0ce1491be5de728
Autor:
Andrea Giordano, Silvia Testa, Marta Bassi, Sabina Cilia, Antonio Bertolotto, Maria Esmeralda Quartuccio, Erika Pietrolongo, Monica Falautano, Monica Grobberio, Claudia Niccolai, Beatrice Allegri, Rosa Gemma Viterbo, Paolo Confalonieri, Ambra Mara Giovannetti, Eleonora Cocco, Maria Grazia Grasso, Alessandra Lugaresi, Elisa Ferriani, Ugo Nocentini, Mauro Zaffaroni, Alysha De Livera, George Jelinek, Alessandra Solari, Rosalba Rosato
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background The Multiple Sclerosis Quality of Life-54 (MSQOL-54) is one of the most commonly-used MS-specific health-related quality of life (HRQOL) measures. It is a multidimensional, MS-specific HRQOL inventory, which includes the generic S
Externí odkaz:
https://doaj.org/article/a5f21a3b4a0b4af6914736cedb5bbad0
Autor:
Nicolò Bruschi, Maria Malentacchi, Simona Malucchi, Francesca Sperli, Serena Martire, Arianna Sala, Paola Valentino, Antonio Bertolotto, Marisa Pautasso, Marco Alfonso Capobianco
Publikováno v:
Neurology and Therapy, Vol 12, Iss 4, Pp 1375-1383 (2023)
Abstract Introduction B-cell-depleting agents have been widely used for neuromyelitis optica spectrum disorder (NMOSD) and MOG-associated diseases (MOGAD), but no consensus exists on the optimal dose and frequency of treatment administration. The aim
Externí odkaz:
https://doaj.org/article/2944d9c64a9d4c5bb73674f02c4391b6
Autor:
Francesca Montarolo, Serena Martire, Fabiana Marnetto, Paola Valentino, Sabdi Valverde, Marco Alfonso Capobianco, Antonio Bertolotto
Publikováno v:
Current Issues in Molecular Biology, Vol 44, Iss 3, Pp 1247-1256 (2022)
Fingolimod (FTY720) and siponimod (BAF312) are selective agonists for sphingosine-1-phosphate (S1P) receptors approved for the treatment of relapsing–remitting (RR) and secondary progressive (SP) multiple sclerosis (MS), respectively. BAF312 exerts
Externí odkaz:
https://doaj.org/article/29b5a292c9e84dbc8f52e6e530a4106f
Autor:
Andrea Giordano, Silvia Testa, Marta Bassi, Sabina Cilia, Antonio Bertolotto, Maria Esmeralda Quartuccio, Erika Pietrolongo, Monica Falautano, Monica Grobberio, Claudia Niccolai, Beatrice Allegri, Rosa Gemma Viterbo, Paolo Confalonieri, Ambra Mara Giovannetti, Eleonora Cocco, Maria Grazia Grasso, Alessandra Lugaresi, Elisa Ferriani, Ugo Nocentini, Mauro Zaffaroni, Alysha De Livera, George Jelinek, Alessandra Solari, Rosalba Rosato
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background MSQOL-54 is a multidimensional, widely-used, health-related quality of life (HRQOL) instrument specific for multiple sclerosis (MS). Findings from the validation study suggested that the two MSQOL-54 composite scores are correlate
Externí odkaz:
https://doaj.org/article/96218f8143a14a98904d53d90fd4b3c0
Autor:
Antonio Bertolotto, Serena Martire, Luca Mirabile, Marco Capobianco, Marco De Gobbi, Daniela Cilloni
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 197-203 (2020)
Abstract Autologous hematopoietic stem cell transplantation (AHSCT) has been used in the treatment of highly active multiple sclerosis (MS) for over two decades. It has been demonstrated to be highly efficacious in relapsing–remitting (RR) MS patie
Externí odkaz:
https://doaj.org/article/63fb3bae40a147a9aa7555f2c0690618
Autor:
Antonio Bertolotto, Rafael Arroyo, Elisabeth G. Celius, Giancarlo Comi, Eva Kubala Havrdova, William David Honeycutt, Samuel F. Hunter, Guillermo Izquierdo, Barbara Kornek, Tamara Miller, Dimos D. Mitsikostas, Barry A. Singer, Tjalf Ziemssen, Luke Chung, Nadia Daizadeh, Salman Afsar, Lobat Hashemi, Peter Senior
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 443-457 (2020)
Plain Language Summary This study looked at alemtuzumab, an approved treatment for multiple sclerosis (MS). People who receive alemtuzumab may develop thyroid problems. The researchers wanted to know whether people who developed thyroid problems with
Externí odkaz:
https://doaj.org/article/3bcc37fc46e84de69be4eb2c49df7148
Autor:
Claudia Desole, Simona Gallo, Annapia Vitacolonna, Elisa Vigna, Cristina Basilico, Francesca Montarolo, Francesca Zuppini, Elena Casanova, Riccardo Miggiano, Davide Maria Ferraris, Antonio Bertolotto, Paolo Maria Comoglio, Tiziana Crepaldi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The Hepatocyte growth factor (HGF) and its receptor (MET) promote several physiological activities such as tissue regeneration and protection from cell injury of epithelial, endothelial, neuronal and muscle cells. The therapeutic potential of MET act
Externí odkaz:
https://doaj.org/article/7fa4ce6435b044b2be29090950ec838a
Autor:
Claudia Desole, Simona Gallo, Annapia Vitacolonna, Francesca Montarolo, Antonio Bertolotto, Denis Vivien, Paolo Comoglio, Tiziana Crepaldi
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Hepatocyte growth factor (HGF) and its tyrosine kinase receptor, encoded by the MET cellular proto-oncogene, are expressed in the nervous system from pre-natal development to adult life, where they are involved in neuronal growth and survival. In thi
Externí odkaz:
https://doaj.org/article/8a25ada7987248ffbf84bd4bdbe1f9a6
Autor:
Valeria Valsecchi, Marina Boido, Francesca Montarolo, Michela Guglielmotto, Simona Perga, Serena Martire, Santina Cutrupi, Andrea Iannello, Nadia Gionchiglia, Elena Signorino, Andrea Calvo, Giuseppe Fuda, Adriano Chiò, Antonio Bertolotto, Alessandro Vercelli
Publikováno v:
Disease Models & Mechanisms, Vol 13, Iss 5 (2020)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects both lower and upper motor neurons (MNs) in the central nervous system. ALS etiology is highly multifactorial and multifarious, and an effective treatment is still lackin
Externí odkaz:
https://doaj.org/article/e0628cfe21604ba9afc32b7db641016e